CONT SUB-PMP-SCHEDULE II&IV

Illinois General Assembly - Full Text of SB3507

Select Language

×

The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.

Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.

The English language version is always the official and authoritative version of this website.

NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.

Choose Language

English

Afrikaans

Albanian

Arabic

Armenian

Azerbaijani

Basque

Bengali

Bosnian

Catalan

Croatian

Czech

Danish

Dutch

Esperanto

Estonian

Filipino

Finnish

French

Galician

Georgian

German

Greek

Gujarati

Haitian Creole

Hausa

Hawaiian

Hebrew

Hindi

Hungarian

Icelandic

Indonesian

Interlingua

Interlingue

Inuktitut

Irish

Italian

Japanese

Javanese

Kannada

Khmer

Korean

Latin

Latvian

Lithuanian

Luxembourgish

Macedonian

Malagasy

Malayalam

Maltese

Maori

Marathi

Myanmar

Nepali

Norwegian

Odia

Pashto

Punjabi

Romanian

Russian

Samoan

Sango

Sanskrit

Sardinian

Sindhi

Sinhala

Slovak

Slovenian

Somali

Southern Sotho

Spanish

Sundanese

Swahili

Swedish

Tamil

Telugu

Thai

Tigrinya

Tonga

Turkish

Ukrainian

Urdu

Vietnamese

Welsh

Xhosa

Yiddish

Yoruba

Zulu

Powered by
Translate

Close

Illinois General Assembly

Top Navigation Bar

Translate

Learn

Select General Assembly

Search the 104th General Assembly

Enter search terms for legislation, members, committees, or schedules.

ILGA.GOV

LEGISLATION & LAWS

Bills & Resolutions

Public Acts

Illinois Compiled Statutes

Illinois Constitution

Search Legislation

Glossary

Guide

Reports & Inquiry

Legislative Reports

Special Reports

FTP Site

Legislator Lookup

Capitol Complex Phone Numbers

Rules & Regulations

Illinois Register

Administrative Rules

Senate

Members

Schedules

Committees

Request for Remote Testimony

Journals

Transcripts

Rules

Audio/Video

FOIA Information

Senate Employment Opportunities

Media Guidelines

House

Members

Schedules

Committees

Submit testimony for House Committees

Journals

Transcripts

Rules

Audio/Video

FOIA Information

House Employment Opportunities

Log In

Mobile Top Bar

Search the 104th General Assembly

Enter keywords to search the Illinois General Assembly website.

Full Text of SB3507

Home

Legislation

Full Text

SB3507 - 104th General Assembly

Bill Status

Full Text

Votes

Witness Slips

Select Menu

Bill Status

Full Text

Votes

Witness Slips

Printer Friendly Version

Introduced

Senate Amendment 001

Senate Amendment 002

Printer Friendly Version

Introduced

Senate Amendment 001

Senate Amendment 002

Open PDF

104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
SB3507

Introduced 2/5/2026, by Sen. Julie A. Morrison

SYNOPSIS AS INTRODUCED:

720 ILCS 570/314.5

Amends the Illinois Controlled Substances Act. Provides that each
prescriber or the prescriber's designee shall document an attempt to
access patient information in the Prescription Monitoring Program to
assess patient access to controlled substances when providing a (rather
than an initial) prescription for Schedule II and IV controlled substances
(rather than narcotics such as opioids), except for prescriptions for
oncology treatment or palliative care, or a 7-day or less supply provided
by a hospital emergency department when treating an acute, traumatic
medical condition.
LRB104 17899 RLC 31335 b

A BILL FOR

SB3507
LRB104 17899 RLC 31335 b
1

AN ACT concerning criminal law.

2

Be it enacted by the People of the State of Illinois,
3
represented in the General Assembly:

4

Section 5.
The Illinois Controlled Substances Act is
5
amended by changing Section 314.5 as follows:

6

(720 ILCS 570/314.5)
7

Sec. 314.5.
Medication shopping; pharmacy shopping.
8

(a) It shall be unlawful for any person knowingly or
9
intentionally to fraudulently obtain or fraudulently seek to
10
obtain any controlled substance or prescription for a
11
controlled substance from a prescriber or dispenser while
12
being supplied with any controlled substance or prescription
13
for a controlled substance by another prescriber or dispenser,
14
without disclosing the fact of the existing controlled
15
substance or prescription for a controlled substance to the
16
prescriber or dispenser from whom the subsequent controlled
17
substance or prescription for a controlled substance is
18
sought.
19

(b) It shall be unlawful for a person knowingly or
20
intentionally to fraudulently obtain or fraudulently seek to
21
obtain any controlled substance from a pharmacy while being
22
supplied with any controlled substance by another pharmacy,
23
without disclosing the fact of the existing controlled

SB3507
- 2 -
LRB104 17899 RLC 31335 b
1
substance to the pharmacy from which the subsequent controlled
2
substance is sought.
3

(c) A person may be in violation of Section 3.23 of the
4
Illinois Food, Drug and Cosmetic Act or Section 406 of this Act
5
when medication shopping or pharmacy shopping, or both.
6

(c-5) Effective January 1, 2018, each prescriber
7
possessing an Illinois controlled substances license shall
8
register with the Prescription Monitoring Program.
9
Notwithstanding any provision of this Act to the contrary,
10
beginning on and after the effective date of this amendatory
11
Act of the 101st General Assembly, a licensed veterinarian
12
shall be exempt from registration and prohibited from
13
accessing patient information in the Prescription Monitoring
14
Program. Licensed veterinarians that are existing registrants
15
shall be removed from the Prescription Monitoring Program.
16
Each prescriber or
the prescriber's

his or her
designee shall
17
also document an attempt to access patient information in the
18
Prescription Monitoring Program to assess patient access to
19
controlled substances when providing
a

an initial
prescription
20
for Schedule II
and IV controlled substances,

narcotics such
21
as opioids,
except for prescriptions for oncology treatment or
22
palliative care, or a 7-day or less supply provided by a
23
hospital emergency department when treating an acute,
24
traumatic medical condition. This attempt to access shall be
25
documented in the patient's medical record. The hospital shall
26
facilitate the designation of a prescriber's designee for the

SB3507
- 3 -
LRB104 17899 RLC 31335 b
1
purpose of accessing the Prescription Monitoring Program for
2
services provided at the hospital.
3

(d) When a person has been identified as having 5 or more
4
prescribers or 5 or more pharmacies, or both, that do not
5
utilize a common electronic file as specified in Section 20 of
6
the Pharmacy Practice Act for controlled substances within the
7
course of a 6-month period, the Prescription Monitoring
8
Program may issue an unsolicited report to the prescribers,
9
dispensers, and their designees informing them of the
10
potential medication shopping. If an unsolicited report is
11
issued to a prescriber or prescribers, then the report must
12
also be sent to the applicable dispensing pharmacy.
13

(e) Nothing in this Section shall be construed to create a
14
requirement that any prescriber, dispenser, or pharmacist
15
request any patient medication disclosure, report any patient
16
activity, or prescribe or refuse to prescribe or dispense any
17
medications.
18

(f) This Section shall not be construed to apply to
19
inpatients or residents at hospitals or other institutions or
20
to institutional pharmacies.
21

(g) Any patient feedback, including grades, ratings, or
22
written or verbal statements, in opposition to a clinical
23
decision that the prescription of a controlled substance is
24
not medically necessary shall not be the basis of any adverse
25
action, evaluation, or any other type of negative
26
credentialing, contracting, licensure, or employment action

SB3507
- 4 -
LRB104 17899 RLC 31335 b
1
taken against a prescriber or dispenser.
2
(Source: P.A. 101-414, eff. 8-16-19; 102-527, eff. 8-20-21.)

Footer

Disclaimer

This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.

Contact ILGA Webmaster

ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies

ILGA.GOV

2026 ILGA.gov | All Rights Reserved |
ADA

|
Disclaimers
|
Learn

This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.
Contact ILGA Webmaster

ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies

ILGA.GOV

2026 ILGA.gov | All Rights Reserved |
ADA

|
Disclaimers
|
Learn